What is the mechanism of action of bimekizumab and how does it differ from other systemic psoriasis treatments?
Featuring Mark Lebwohl, MD | Senior Clinical Advisor |

Dean for Clinical Therapeutics
Waldman Professor
Chairman Emeritus
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

| Published November 06, 2023
Loading...
Loading...
Loading...
Dermsquared

The leading platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved